Development of an Efficient Process for a Key Synthetic Intermediate of the SGLT2 Inhibitor LH-1801
Pharmaceutical Fronts · 01.09.2025 · 07 (03) · e201-e209
DOI: 10.1055/a-2670-2258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.09.2025. Verfasst von Jun Qu und 9 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(2-Bromo-5-chloro-4-((5-ethylthiophen-2-yl)methyl)phenyl)methanol (1) is a key intermediate of the SGLT2 inhibitor LH-1801. This study aimed to explore an efficient process for the synthesis of 1 on a large scale. In this work, the synthetic route started with 3-amino-4-methylbenzoic acid methyl ester (2), followed by (1) bromination, (2) diazotization–Sandmeyer reaction, (3) the oxidation of the benzylic hydrogen to give the corresponding benzoic acid, (4) Friedel–Crafts acylation, and (5) reduction of a carbonyl group (C = O) into a methylene group (–CH2–) to achieve the target product. We optimized the diazotization-Sandmeyer reaction conditions and reaction parameters for a successful oxidation sequence. In addition, a reduction system for Step 5 was screened. With the optimal reduction system (NaBH4/BF3•THF) in hand, the target product (1) could be generated in an efficient and concise one-step reduction approach. Given the above, the synthesis route with process optimization delivered the target product (1) in only five steps with an overall yield of 18.9% and a purity higher than 99%.
Zitieren
APA
Qu, J., Hu, Z., Zhang, P., Wu, H., Xue, H., Cai, L., Sun, X., Qian, Y., Peng, R., & Gao, D. (2025). Development of an Efficient Process for a Key Synthetic Intermediate of the SGLT2 Inhibitor LH-1801. Pharmaceutical Fronts, 07(03), e201-e209. https://doi.org/10.1055/a-2670-2258
Vancouver
Qu J, Hu Z, Zhang P, Wu H, Xue H, Cai L, et al. Development of an Efficient Process for a Key Synthetic Intermediate of the SGLT2 Inhibitor LH-1801. Pharmaceutical Fronts. 2025;07(03):e201-e209. doi:10.1055/a-2670-2258
BibTeX
@article{Qu2025,
author = {Qu, Jun and Hu, Zhong and Zhang, Pengcheng and Wu, Hongxiang and Xue, Honglan and Cai, Lei and Sun, Xingxing and Qian, Yun and Peng, Rongrong and Gao, Dehua},
title = {Development of an Efficient Process for a Key Synthetic Intermediate of the SGLT2 Inhibitor LH-1801},
journal = {Pharmaceutical Fronts},
year = {2025},
volume = {07},
number = {03},
pages = {e201--e209},
doi = {10.1055/a-2670-2258}
}
EUVIMED